Shares of Baxter International Inc. slid 4.37% to $20.15 Monday, on what proved to be an all-around favorable trading session ...

What Happened? Shares of healthcare company Baxter International (NYSE:BAX) fell 4.5% in the afternoon session after Barclays ...

In a first-of-its-kind partnership for Baxter, the medtech company said Jan. 8 it is partnering with Charleston, S.C.-based MUSC Health to support the health system’s nursing workforce.  With a focus ...

Baxter International, a global healthcare products company with more than $15 billion in annual revenue, kicked off 2023 with the new year’s resolution of becoming streamlined and nimble. Five months ...

Baxter stock (NYSE: BAX) currently trades at $41 per share, more than 50% lower than the level seen in March 2021, and it can see higher levels over time. BAX stock was trading at around $64 in early ...

Baxter has laid out plans to spin off its global kidney care operations into a new, publicly traded enterprise. The move follows a string of major medtechs in the past year pushing their internal ...

Baxter has settled on a name for its $4.5 billion kidney care division, which is slated to strike out on its own as an independent portfolio of dialysis machines, acute renal therapies and services.